We are live on ! Find out more
Macquarie Group

Macquarie Group Portfolio holdings

AUM $16.8B
1-Year Est. Return 27.39%
This Fund
S&P 500
This Quarter Est. Return
+2.1%
1 Year Est. Return
+27.39%
3 Year Est. Return
+81.07%
5 Year Est. Return
+109.03%
10 Year Est. Return
+396.55%
AUM
$87.2B
AUM Growth
-$982M
Cap. Flow
-$1.89B
Cap. Flow %
-2.16%
Top 10 Hldgs %
17.52%
Holding
2,206
New
298
Increased
599
Reduced
739
Closed
319

Top Buys

Rank Stock Value
1
J icon
Jacobs Solutions
J
+$291M
2
HSY icon
Hershey
HSY
+$278M
3
CVX icon
Chevron
CVX
+$274M
4
APD icon
Air Products & Chemicals
APD
+$268M
5
SAP icon
SAP
SAP
+$240M

Top Sells

Rank Stock Value
1
AIG icon
American International
AIG
+$347M
2
DG icon
Dollar General
DG
+$290M
3
WDAY icon
Workday
WDAY
+$225M
4
PINS icon
Pinterest
PINS
+$165M
5
INTU icon
Intuit
INTU
+$150M

Sector Composition

Rank Sector Weight
1 Technology 27.47%
2 Healthcare 12.88%
3 Financials 11.68%
4 Industrials 10.33%
5 Consumer Discretionary 10.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BLND icon
1876
Blend Labs
BLND
$409M
-15,755
Closed -$51
BLZE icon
1877
Backblaze
BLZE
$697M
-1,589
Closed -$16
BSM icon
1878
Black Stone Minerals
BSM
$3.11B
-124,827
Closed -$2M
BUR icon
1879
Burford Capital
BUR
$907M
-5,016
Closed -$80
BVS icon
1880
Bioventus
BVS
$799M
-1,809
Closed -$9
BYFC icon
1881
Broadway Financial
BYFC
$94.9M
-167
Closed -$1
BYRN icon
1882
Byrna Technologies
BYRN
$80.3M
-714
Closed -$10
CABO icon
1883
Cable One
CABO
$213M
-25
Closed -$11K
CACC icon
1884
Credit Acceptance
CACC
$6B
-75
Closed -$41K
CALX icon
1885
Calix
CALX
$2.27B
-119
Closed -$4K
CAPR icon
1886
Capricor Therapeutics
CAPR
$1.14B
-941
Closed -$6
CAR icon
1887
Avis
CAR
$5.63B
-150,000
Closed -$18.4K
CATX icon
1888
Perspective Therapeutics
CATX
$332M
-1,399
Closed -$17
CBUS icon
1889
Cibus
CBUS
$130M
-675
Closed -$15
CCCC icon
1890
C4 Therapeutics
CCCC
$376M
-4,009
Closed -$33
CDT icon
1891
CDT Equity Inc
CDT
$1.93M
0
-$1
CENN icon
1892
Cenntro
CENN
$8.23M
-80
Closed -$7
CHX
1893
DELISTED
ChampionX
CHX
-100,412
Closed -$3.6M
COCH icon
1894
Envoy Medical
COCH
$51M
-344
Closed -$1
CRBP icon
1895
Corbus Pharmaceuticals
CRBP
$170M
-507
Closed -$20
CRDF icon
1896
Cardiff Oncology
CRDF
$64.3M
-1,368
Closed -$7
CRSP icon
1897
CRISPR Therapeutics
CRSP
$4.58B
-27,678
Closed -$1.89M
CSPI icon
1898
CSP Inc
CSPI
$80.1M
-144
Closed -$3
CSTE icon
1899
Caesarstone
CSTE
$72.3M
-322
Closed -$1
CTMX icon
1900
CytomX Therapeutics
CTMX
$705M
-1,134
Closed -$2

Similar funds

Macquarie Group's Q2 2024 Portfolio in Review

As of Q2 2024, Macquarie Group held 2,206 positions worth $87.2B, down 1.1% from $88.2B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Macquarie Group's Q2 2024 filing shows 298 new, 599 increased, 739 reduced and 319 closed positions. Its largest new stake was AppFolio: 251,518 shares worth $61.5M. The largest sale was American International, an estimated $347M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 25% a quarter earlier, followed by Healthcare and Financials.

  • Macquarie Group's largest Q2 2024 buy was AppFolio: 251,518 shares worth $61.5M.
  • Macquarie Group added most to Jacobs Solutions in Q2 2024, an estimated $291M increase.
  • Macquarie Group's biggest Q2 2024 reduction was American International, cutting an estimated $347M.
  • Macquarie Group fully exited Vanguard Russell 2000 ETF in Q2 2024, selling an estimated $110M.
  • Macquarie Group's ten largest holdings make up 18% of its $87.2B portfolio in Q2 2024.
  • Macquarie Group opened 298 new positions and closed 319 in Q2 2024.
  • Macquarie Group's portfolio value fell 1.1% quarter-over-quarter to $87.2B.

Based on Macquarie Group's 13F filing for Q2 2024, filed 9 Aug 2024.